Internal Medicine · Auburn, AL
NPI
1891835294
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1548 Professional Pkwy
Auburn, AL, 36830
Phone (334) 826-2901
Groups this clinician bills Medicare through
Medicare paid, 2024
$200K
8,157 services
Medicare patients, 2024
604
Average age 75
Drug cost, 2024
$1.0M
10,964 prescriptions
Company payments, 2025
$492
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John A Abrams II was code 99213 (office e&m - established), 1,169 times for 449 patients. In total John A Abrams II billed 8,157 services in 36 codes, and Medicare paid $200K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,169 | 449 | $53.17 | $62K |
| 96372 Injection Administration | Office | 451 | 90 | $9.01 | $4,065 |
| 99232 Hospital E&M - Subsequent | Facility | 393 | 85 | $60.32 | $24K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 382 | 382 | $123.70 | $47K |
| 99212 Office E&M - Established | Office | 141 | 107 | $32.90 | $4,639 |
| G0008 Administration of influenza virus vaccine | Office | 120 | 120 | $29.40 | $3,528 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 96 | 35 | $0.90 | $85.99 |
| 90653 Vaccine Product | Office | 95 | 95 | $80.96 | $7,691 |
| 87428 Infectious Agent Detection by DNA/RNA | Office | 94 | 81 | $63.70 | $5,988 |
| 81003 Clinical Chemistry | Office | 90 | 60 | $2.18 | $196 |
| 99238 Hospital Discharge Management | Facility | 75 | 57 | $61.78 | $4,634 |
| 99223 Hospital E&M - Initial | Facility | 74 | 56 | $127.56 | $9,439 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 57 | 29 | $3.30 | $188 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 56 | 28 | $0.10 | $5.69 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 42 | 33 | $37.50 | $1,575 |
By year: 2022 $212K for 7,417 services; 2023 $202K for 7,714 services; 2024 $200K for 8,157 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87428 Infectious Agent Detection by DNA/RNA | 94 | 81 | $63.70 | $5,988 |
| 81003 Clinical Chemistry | 90 | 60 | $2.18 | $196 |
Medicare prescription drug claims, 2024
In 2024, the drug John A Abrams II prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 529 prescriptions and refills. In total John A Abrams II wrote 10,964 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 529 | 529 | 104 | $6,047 |
| Levothyroxine Sodium Generic | 413 | 984 | 115 | $5,896 |
| Gabapentin Generic | 344 | 573 | 99 | $3,424 |
| Amlodipine Besylate Generic | 320 | 636 | 76 | $1,843 |
| Losartan Potassium Generic | 313 | 780 | 99 | $4,045 |
| Pantoprazole Sodium Generic | 300 | 562 | 86 | $2,791 |
| Atorvastatin Calcium Generic | 257 | 646 | 82 | $3,183 |
| Rosuvastatin Calcium Generic | 199 | 570 | 82 | $3,984 |
| Tramadol Hcl Generic | 187 | 187 | 67 | $764 |
| Alprazolam Generic | 173 | 178 | 61 | $817 |
| Meloxicam Generic | 166 | 270 | 48 | $825 |
| Omeprazole Generic | 163 | 458 | 59 | $2,865 |
| Ozempic Semaglutide | 159 | 208 | 32 | $172K |
| Potassium Chloride Generic | 157 | 355 | 57 | $3,773 |
| Eliquis Apixaban | 156 | 261 | 40 | $139K |
Brand drugs: 1,461 claims; generic drugs: 9,436 claims; opioid claims: 1,127.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John A Abrams II $492 ($492 in general payments such as food, travel and fees) from 12 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $152.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $152 |
| Lilly USA, LLC LLY | 3 | $53.06 |
| Novo Nordisk Inc NVO | 3 | $51.75 |
| Exact Sciences Corporation EXAS | 2 | $36.71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $35.69 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $34 |
| Abbvie Inc. ABBV | 2 | $31.31 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $28.27 |
| Pfizer Inc. PFE | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $17.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.